Profiles of surface mosaics on chronic lymphocytic leukemias distinguish stable and progressive subtypes
Chronic lymphocytic leukemia (CLL) is a heterogeneous disease, some patients may survive for many years, while 20-30% of patients progress and may die within several years. Currently, there is not a single procedure that enables accurate prognosis and triaging of those patients who need immediate an...
Saved in:
Published in | Journal of pharmacy & pharmaceutical sciences Vol. 16; no. 2; pp. 231 - 237 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Canada
Frontiers Media S.A
01.01.2013
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!